Medtronic brain device OK’d for new use
Medtronic Inc. said Thursday that it has received European regulatory approval to use its deep brain stimulation therapy to control seizures in some epilepsy patients.
The Fridley-based medical technology giant has developed an implantable, pacemaker-like device that delivers controlled electrical pulses to the part of the brain that involve seizures.
European approval, called CE Mark, was based on a 110-patient clinical trial that was conducted at 17 hospitals in the United States, none of them in Minnesota.
While the World Health Organization estimates that 50 million people suffer from epilepsy, Medtronic's recent European approval covers a small subset of adults who suffer from "partial-onset seizures" that affect only a certain part of the brain. These patients typically cannot control their seizures solely with drugs.
- CVS Ramps Up Retail Clinics with Provider Affiliations
- 4 Tectonic Shifts Shaking Up Healthcare
- Medical Errors Third Leading Cause of Death, Senators Told
- As States Regulate Provider Competition, Common Threads Emerge
- Chronic Disease Care Costs Get Bipartisan Attention
- CareFirst Announces PCMH Program Results
- Mayo Tops U.S. News Best Hospitals Rankings
- Hospitals Seeking to Understand PPACA Impact Turn to Data
- Telemedicine Providers Welcome AMA Guidelines
- Recruiting Retired Clinicians